Agency for Healthcare Research and Quality (AHRQ)

Disclosures

March 01, 2012

In This Article

Comparison of Recommendations: Metabolic and Renal Factors

ACCF/AHA (2010)

Class II b

Measurement of HbA1C may be reasonable for cardiovascular risk assessment in asymptomatic adults without a diagnosis of diabetes (Khaw et al., 2004; Khaw & Wareham, 2006; Knowler et al., 2002; Lachin et al., 2007; Selvin et al., 2004; Selvin et al., 2010). (Level of Evidence: B)

Class II b

In asymptomatic adults at intermediate risk without hypertension or diabetes, urinalysis to detect microalbuminuria might be reasonable for cardiovascular risk assessment (Arnlov et al., 2005). (Level of Evidence: B)

NACB (2009)

  1. CKD testing is not routinely recommended if the 10-year predicted risk is <5% without specific CKD or CVD risk factors, either for CKD detection or CVD risk assessment. (Classification of recommendation: III [against routine measurement]; Level of evidence: C)

  2. CKD testing, including serum creatinine for GFR [glomerular filtration rate] estimation and microalbuminuria, for primary prevention should be performed for all individuals with hypertension, diabetes mellitus, family history of CKD, and those at intermediate risk (10% to 20%) for CVD. In addition, measurement of serum creatinine for GFR estimation should be performed in all individuals >65 years old. Individual decisions are recommended in those with other CKD risk factors. (Classification of recommendation: IIa; Level of evidence: B)

USPSTF (2009)

No recommendations provided.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....